Neoadjuvant SF-SBRT Plus Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC.

Clinical trial NCT07608159 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07608159
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer Stereotactic Body Radiotherapy Neoadjuvant Chemoimmunotherapy Surgery

Start date: 2026-05-01
Primary completion: 2029-05-01
Enrollment: 201

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.